Daniil Gataulin

Stock Analyst at Chardan Capital

(4.89)
# 64
Out of 5,033 analysts
117
Total ratings
65.71%
Success rate
63.55%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Daniil Gataulin

Opus Genetics
Oct 16, 2025
Initiates: Buy
Price Target: $9
Current: $1.98
Upside: +354.55%
Oculis Holding AG
Oct 8, 2025
Maintains: Buy
Price Target: $33$51
Current: $21.82
Upside: +133.73%
Kodiak Sciences
Oct 6, 2025
Maintains: Neutral
Price Target: $14
Current: $17.70
Upside: -20.90%
Ocular Therapeutix
Oct 2, 2025
Maintains: Buy
Price Target: $21
Current: $12.18
Upside: +72.41%
Zura Bio
Sep 30, 2025
Maintains: Buy
Price Target: $10
Current: $3.37
Upside: +196.74%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $35$76
Current: $63.92
Upside: +18.90%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.62
Upside: +332.10%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $70$48
Current: $47.93
Upside: +0.15%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $12.64
Upside: +311.39%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.48
Upside: +102.70%
Maintains: Buy
Price Target: $61
Current: $12.19
Upside: +400.41%
Maintains: Buy
Price Target: $35
Current: $8.24
Upside: +324.76%
Maintains: Buy
Price Target: $33
Current: $4.46
Upside: +639.91%
Maintains: Buy
Price Target: $15
Current: $7.51
Upside: +99.73%
Maintains: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
Maintains: Buy
Price Target: $27
Current: $12.03
Upside: +124.44%
Downgrades: Neutral
Price Target: n/a
Current: $4.09
Upside: -
Maintains: Buy
Price Target: $220
Current: $0.58
Upside: +37,978.75%